Zusammenfassung
Der früher zur Krebsdiagnose vorgeschlagene Plasma-Methylenblau-Entfärbungstest nachSavignac 2 undBlack 3 spricht im wesentlichen auf die Plasma-Selenkonzentration an. Daraus ergeben sich Hinweise für die möglicherweise krebsschützende Wirkung des Selens, die durch statistische Daten gestützt wird.
Literatur
R. J. Shamberger andD. V. Frost, Can. med. Ass. J.100, 682 (1969).
R. J. Savignac, J. C. Gant andI. W. Sizer, Am. Ass. adv. Sci. Res. Conference on Cancer,1945, p. 241–252.
Also seeR. J. Winzler, Adv. Cancer Res.1, 519 (1953).
M. M. Black andF. D. Speer, Am. J. clin. Path.20, 446 (1950).
N. Eriksen, L. D. Ellerbrook andS. W. Lippincott, J. Am. Cancer Inst.7, 705 (1951).
C. Huggins, E. V. Jensen, M. A. Player andV. D. Hospelhorn, Cancer. Res.9, 753 (1949).
D. C. Harrison, Biochem. J.22, 335 (1928).
G. N. Schrauzer andJ. W. Sibert, Archs Biochem. Biophys.130, 257 (1969).
F. Feigl andPh. West, Analyt. Chem.19, 351 (1947).
Determined by Dr.E. E. Cary, Ithaca, N.Y.
O. E. Olson, J. Ass. off. analyt. Chem.52, 627 (1969).
R. R. Cavalieri andK. G. Scott, J. Am. med. Ass.206, 591 (1968).
J. Kubota, W. H. Allaway, D. L. Carter, E. E. Cary andV. A. Lazar, J. Agr. Food Chem.15, 448 (1967).
Vital Statistics Abstracts, U.S., 1967.
Author information
Authors and Affiliations
Additional information
This research was supported by Grants of the Academic Senate, University of California, San Diego, and Grant No. GP 28485 X of the National Science Foundation.
Rights and permissions
About this article
Cite this article
Schrauzer, G.N., Rhead, W.J. Interpretation of the methylene blue reduction test of human plasma and the possible cancer protecting effect of selenium. Experientia 27, 1069–1071 (1971). https://doi.org/10.1007/BF02138885
Issue Date:
DOI: https://doi.org/10.1007/BF02138885